Value of Renal Vascular Doppler Sonography in Cardiorenal Syndrome Type 1


Çakal B., ÖZCAN Ö. U., Omaygenç M. O., KARACA I. O., Kızılırmak F., GÜNEŞ H. M., ...Daha Fazla

Journal of Ultrasound in Medicine, cilt.40, sa.2, ss.321-330, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1002/jum.15404
  • Dergi Adı: Journal of Ultrasound in Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, Compendex, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.321-330
  • Anahtar Kelimeler: decompensated heart failure, diuretics, renal resistive index, venous impedance index
  • İstanbul Medipol Üniversitesi Adresli: Evet

Özet

Objectives: Worsening of renal function in a patient with acute decompensated heart failure is called cardiorenal syndrome (CRS) type 1. Recent studies have shown an association of persistent systemic venous congestion with renal dysfunction. This trial was set up to investigate the changes of renal Doppler parameters with diuretic therapy in patients with CRS type 1. Methods: Cases of CRS type 1 were identified among patients hospitalized for decompensated heart failure. Serial measurements of the renal venous impedance index (VII) and arterial resistive index (ARI) were calculated by pulsed wave Doppler sonography. Results: A total of 30 patients who had creatinine improvement with diuresis (group 1) and 34 patients without any improvement (group 2) were analyzed. Patients in group 1 had higher median VII and ARI (VII, 0.86 versus 0.66; P <.001; ARI, 0.78 versus 0.65; P <.001) on admission. A high ARI on admission (odds ratio, 6.25; 95% confidence interval, 1.84–14.3; P =.003) predicted the improvement of serum creatinine levels with diuretic therapy independent of confounding factors in patients with CRS type 1. Conclusions: Renal vascular Doppler parameters might offer guidance on the diagnostic and therapeutic strategies in prescribing decongestive therapy for decompensated heart failure.